Survival, quality of life and breast cancer

P. Mosconi, M. Colozza, M. De Laurentiis, S. De Placido, M. Maltoni

Research output: Contribution to journalArticlepeer-review


In recent years, evaluating quality of life (QoL) has become increasingly important as an additional measured outcome in cancer clinical trials, in particular in the field of breast cancer. This paper, after a general introduction to the present debate on the methodological issues involved in QoL evaluation, reviews results and open questions regarding the use of this measure in surgical, adjuvant and metastatic studies.

Original languageEnglish
JournalAnnals of Oncology
Issue numberSUPPL. 3
Publication statusPublished - 2001


  • Adjuvant treatment
  • Breast cancer
  • Metastatic disease
  • Quality of life
  • Surgical treatment

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Survival, quality of life and breast cancer'. Together they form a unique fingerprint.

Cite this